Clinical Trial Update: Clinical Study of BCT301 Cell Injection Therapy for Refractory Autoimmune Diseases [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 clinical trial evaluating BCT301 cell injection therapy for refractory autoimmune diseases, including systemic lupus erythematosus and systemic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anca-associated Vasculitis
• Antiphospholipid Syndrome
• Inflammatory Myositis
• Sjögren Syndrome
• Systemic Lupus Erythematosus
• Systemic Sclerosis

Drugs mentioned

• BCT301 cell injection therapy (BCT301)

Snippet

Sponsor: Peking University Third Hospital | Conditions: System Lupus Erythematosus, Systemic Sclerosis (SSc) | EARLY_Phase 1 | Status: NOT_YET_RECRUITING